AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with over USD 50 billion in investment, their help during the pandemic, the chamber’s efforts to develop local talent and take advantage of the country’s advanced healthcare infrastructure to promote medical tourism, and explains how American pharma companies are focusing on R&D investment.
US investment decides where to go for periods of 7-10 years, so Turkey has to be ready so as not to miss the window of opportunity and have to wait up to a decade to receive big projects
